Predictors of Inadequate Serum Urate Response to Low-Dose Febuxostat in Male Patients with Gout.

Wenyan SunXuetong ZhaoNicola DalbethRobert TerkeltaubLingling CuiZhen LiuLin HanCan WangHui ZhangYiming BaoChanggui LiJie Lu

Published in: Journal of inflammation research (2024)

Response to low-dose febuxostat is associated with early sUA improvement in individual patients, as well as patient age, BMI, and levels of TG and CRP.

Keyphrases

low dose
end stage renal disease
high dose
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
case report
patient reported outcomes
physical activity
weight loss